Italian merger set in drug ingredients | Chemical & Engineering News
Volume 94 Issue 22 | p. 15 | Concentrates
Issue Date: May 30, 2016

Italian merger set in drug ingredients

Department: Business
Keywords: pharmaceutical chemicals, Italy

The Italian firm Olon has acquired its rival Infa in a deal that will create one of Europe’s largest pharmaceutical chemical makers. The combined company expects its sales this year to exceed $335 million. It will operate seven plants in Italy and one in Spain that make active ingredients for generic drugs and provide contract manufacturing. The combined firm is owned by Italy’s P&R Group, which also owns the drug company Fidia Farmaceutici and the resin maker Sir Industriale.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment